Cargando…
Prevalence of Phosphodiesterase-5 Inhibitor Use in the VHA in 2004 and 2005 Is Twice That of a Commercial Health Plan in 2001
Autores principales: | French, Dustin D., Margo, Curtis E., Campbell, Robert R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438309/ https://www.ncbi.nlm.nih.gov/pubmed/17269850 http://dx.doi.org/10.18553/jmcp.2006.12.8.692 |
Ejemplares similares
-
Short-Term Medical Costs of a VHA Health Information Exchange: A CHEERS-Compliant Article
por: French, Dustin D., et al.
Publicado: (2016) -
Israel Seminar 2004-2005
por: Milman, Vitali, et al.
Publicado: (2007) -
Human Metapneumovirus, Australia, 2001–2004
por: Sloots, Theo P., et al.
Publicado: (2006) -
Proyectos de vinculación 2001-2004.
Publicado: (2005) -
Effects of VHA Policy Directive 1163 on Acceptance and Employment Rates for Veterans with Substance Use Disorders Referred to VHA Vocational Rehabilitation
por: Sprong, Matthew E, et al.
Publicado: (2022)